Radiopharm Theranostics Limited RADX
RADX
Radiopharm Theranostics Limited TCRT
Alaunos Therapeutics, Inc. IBO
Impact BioMedical Inc. QNRX
Quoin Pharmaceuticals, Ltd. NBY
NovaBay Pharmaceuticals, Inc. BCLI
Brainstorm Cell Therapeutics Inc. CDIO
Cardio Diagnostics Holdings, Inc. ADXN
Addex Therapeutics Ltd MTNB
Matinas BioPharma Holdings, Inc. KTTA
Pasithea Therapeutics Corp.
Radiopharm Theranostics Limited TCRT
Alaunos Therapeutics, Inc. IBO
Impact BioMedical Inc. QNRX
Quoin Pharmaceuticals, Ltd. NBY
NovaBay Pharmaceuticals, Inc. BCLI
Brainstorm Cell Therapeutics Inc. CDIO
Cardio Diagnostics Holdings, Inc. ADXN
Addex Therapeutics Ltd MTNB
Matinas BioPharma Holdings, Inc. KTTA
Pasithea Therapeutics Corp.
Performance
| Periode | RADX | TCRT | IBO | QNRX | NBY | BCLI | CDIO | ADXN | MTNB | KTTA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 15.08 % | -17.02 % | 79.26 % | 63.22 % | 829.82 % | -54.10 % | -12.94 % | -7.45 % | -20.55 % | 55.08 % |
| YTD | 11.85 % | 80.71 % | -57.85 % | -39.63 % | 741.27 % | -73.83 % | -87.68 % | 3.85 % | 23.35 % | -60.41 % |
| 1Y | 18.22 % | 81.63 % | -44.04 % | -28.71 % | 900.00 % | -75.44 % | -88.94 % | -0.89 % | 33.08 % | -55.89 % |
| 3Y | -70.63 % | -96.15 % | -75.78 % | -97.73 % | -89.41 % | -97.95 % | -88.67 % | -35.61 % | -97.21 % | -91.47 % |
| 5Y | -70.63 % | -99.15 % | -75.78 % | -99.97 % | -99.31 % | -99.28 % | -98.90 % | -96.87 % | -98.61 % | -98.37 % |
| 10Y | -70.63 % | -99.71 % | -75.78 % | -100.00 % | -99.88 % | -98.65 % | -98.90 % | -96.54 % | -98.09 % | -98.37 % |
| From the beginning | -70.63 % | -99.85 % | -75.78 % | -100.00 % | -100.00 % | -77.87 % | -98.90 % | -96.54 % | -98.88 % | -98.37 % |